TransCode Therapeutics Q4 2024 Earnings Deep Losses Reflect PreRevenue Stage Tiptree Inc TIPT Q2 2025 Earnings Strong Earnings Per Share of 058 Drives Positive Market Response BeyondSpring BYSI Q1 2026 Earnings Narrowing Loss and No Revenue as ClinicalStage Biotech Advances Pipeline PLXS Q1 2026 Earnings EPS Beat of 678 Surprises Stock Slips 285 CZFS Q1 2026 Earnings EPS Beat of 695 Lifts Shares as Revenue Details Remain Undisclosed BOC Q4 2025 Earnings Deep Loss Misses Estimate Despite Stock Rebound